Trial Details
TERMINATEDBasic Information
| Clinical ID | c1171 |
|---|---|
| Identifier | NCT05470985 |
| Trial Title | A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Ozanimod |
Participant Information
| Sponsor | Bristol-Myers Squibb |
|---|---|
| City | Garden Grove |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2|PHASE3 |
Time Information
| Start Date | 2023-08-22 |
|---|---|
| Primary Completion Date | 2024-09-13 |
| Completion Date | 2024-09-13 |